Modin Daniel, Claggett Brian, Johansen Niklas Dyrby, Solomon Scott D, Trebbien Ramona, Grove Krause Thyra, Stæhr Jensen Jens-Ulrik, Porsborg Andersen Mikkel, Gislason Gunnar, Biering-Sørensen Tor
Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, Copenhagen, Denmark.
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
J Am Coll Cardiol. 2024 Dec 17;84(25):2460-2467. doi: 10.1016/j.jacc.2024.08.048. Epub 2024 Aug 31.
Influenza virus may cause severe infection in patients with heart failure. It is known that influenza infection is associated with increased morbidity and mortality in patients with heart failure. However, less is known about the excess burden of morbidity and mortality caused by influenza infection in patients with heart failure at a population level.
The purpose of this study was to estimate the excess burden of morbidity and mortality as determined by annual excess number of deaths and hospitalizations associated with influenza infection in patients with heart failure in Denmark.
We collected nationwide data on weekly number of deaths and hospitalizations among patients with heart failure in Denmark and weekly estimates of influenza circulation as determined by the proportion of positive influenza samples analyzed at all Danish Hospitals. These data were correlated in a time series linear regression model, and this model was used to estimate the annual excess number of deaths and hospitalizations attributable to influenza circulation among patients with heart failure in Denmark. The model also included data on weekly mean temperature and restricted cubic spline terms to account for seasonality and trends over time.
Data were available from 2010 to 2018 encompassing 8 influenza seasons with an annual mean of 25,180 samples tested for influenza at Danish hospitals. Among an annual mean of 70,570 patients with heart failure, our model estimated that influenza activity was associated with an annual excess of 250 all-cause deaths (95% CI: 144-489 deaths) corresponding to 2.6% of all all-cause deaths (95% CI: 1.5%-5.1%) in patients with heart failure. Similarly, influenza activity was associated with an annual excess of 115 cardiovascular deaths (95% CI: 62-244 deaths) corresponding to 2.9% of all cardiovascular deaths (95% CI: 1.5%-6.1%). Influenza activity was also associated with an annual excess of 251 hospitalizations for pneumonia or influenza (95% CI: 107-533 hospitalizations) corresponding to 5.0% of all hospitalizations for pneumonia or influenza.
Our results indicate that influenza activity likely causes substantial morbidity and mortality among patients with heart failure. Notably, our study suggests that approximately 2.6% of all deaths and 5.0% of all hospitalizations with influenza or pneumonia may be attributed to influenza in patients with heart failure.
流感病毒可能导致心力衰竭患者发生严重感染。已知流感感染与心力衰竭患者发病率和死亡率的增加有关。然而,在人群层面上,关于流感感染给心力衰竭患者带来的额外发病和死亡负担,我们了解得较少。
本研究的目的是通过丹麦心力衰竭患者中与流感感染相关的年度额外死亡数和住院数来估计额外的发病和死亡负担。
我们收集了丹麦全国范围内心力衰竭患者每周的死亡数和住院数数据,以及通过丹麦所有医院分析的流感阳性样本比例确定的每周流感传播估计值。这些数据在时间序列线性回归模型中进行关联,该模型用于估计丹麦心力衰竭患者中因流感传播导致的年度额外死亡数和住院数。该模型还包括每周平均温度数据和受限立方样条项,以考虑季节性和随时间的趋势。
可获得2010年至2018年的数据,涵盖8个流感季节,丹麦医院每年平均检测25,180份流感样本。在每年平均70,570名心力衰竭患者中,我们的模型估计,流感活动与每年额外250例全因死亡相关(95%置信区间:144 - 489例死亡),占心力衰竭患者全因死亡总数的2.6%(95%置信区间:1.5% - 5.1%)。同样,流感活动与每年额外115例心血管死亡相关(95%置信区间:62 - 244例死亡),占所有心血管死亡总数的2.9%(95%置信区间:1.5% - 6.1%)。流感活动还与每年额外251例因肺炎或流感住院相关(95%置信区间:107 - 533例住院),占所有因肺炎或流感住院总数的5.0%。
我们的结果表明,流感活动可能在心力衰竭患者中导致大量发病和死亡。值得注意的是,我们的研究表明,心力衰竭患者中约2.6%的所有死亡以及5.0%的所有因流感或肺炎住院可能归因于流感。